East China medicine: the subsidiary ornidazole tablets passed the conformity evaluation of generic drugs
Financial Associated Press, September 29 - East China medicine announced that the ornidazole tablets produced by the company's wholly-owned subsidiary East China Medicine (Xi'an) Bohua Pharmaceutical Co., Ltd. passed the consistency evaluation of generic drug quality and efficacy. Ornidazole is used to treat a variety of diseases caused by anaerobic infection, such as Trichomonas urogenital tract infection in men and women, Giardia flagellate infection and so on.
This text is a result of machine translation.
Related companies：
In-depth
Technology
DeepSeek | China's AI Global Breakthrough and Ecosystem Restructuring
Mar 19, 2025 01:18 PM
Jan 30, 2024 07:59 PM
Dec 11, 2023 08:49 PM
Jan 06, 2023 08:30 AM
Jan 05, 2023 07:33 PM
Sunshine City responded to the rumor that the interest extension plan was approved: the news is true
Briefing Jan 18, 2022 01:49 PM
· Technology
The trading amount of well-off shares was nearly 1.5 billion
See more
Read next
Insight
In-depth
Automotive · Analysis
Chinese Automakers Break into a €10 Billion Market in Europe
Apr 11, 2025 09:57 PM
Insight
In-depth
Automotive · Analysis
Tariff Escalation Through the Lens of Geopolitical Economy
Apr 11, 2025 12:32 PM
Insight
In-depth
Consumer Staples · Analysis
China’s “Dark Cuisine” and Southeast Asia’s Wealth Code
Apr 07, 2025 03:46 PM
Insight
In-depth
